机构：[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China四川大学华西医院[2]Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China[3]Department of Pathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo City, Zhejiang Province, 315211, China[4]Department of Urology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院[5]Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN, 47907, USA[6]Purdue Institute for Cancer Research, Purdue University, West Lafayette, IN, USA[7]Department of Public Research Platform, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China台州恩泽医疗中心台州医院[8]Department of Urological Surgery, Daping Hospital, Army Medical Center of PLA, Army Medical University, Chongqing, China[9]Department of Urology, Kyung Hee University, South Korea [10]Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region of China[11]Division of Surgery & Interventional Science, University College London, London, W1W 7TS, UK
第一作者机构：[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Li Dengxiong,Shao Fanglin,Li Xinrui,et al.Advancements and Challenges of R-loops in Cancers: Biological Insights and Future Directions[J].Cancer Letters.2025,610:217359.doi:10.1016/j.canlet.2024.217359.
APA：
Li Dengxiong,Shao Fanglin,Li Xinrui,Yu Qingxin,Wu Ruicheng...&Feng Dechao.(2025).Advancements and Challenges of R-loops in Cancers: Biological Insights and Future Directions.Cancer Letters,610,
MLA：
Li Dengxiong,et al."Advancements and Challenges of R-loops in Cancers: Biological Insights and Future Directions".Cancer Letters 610.(2025):217359
医学